E-LIB Suche - Ergebnisse für: Veerman, G. D. Marijn

1

Quantitative modeling of tumor dynamics and development of ..:

Yin, Anyue ; Veerman, G. D. Marijn ; van Hasselt, Johan G. C....
CPT: Pharmacometrics & Systems Pharmacology. 13 (2024) 4 - p. 612-623 , 2024

Link: https://doi.org/10.1002/..

2

Osimertinib Plasma Trough Concentration in Relation to Brai..:

Gulikers, Judith L. ; Veerman, G.D. Marijn ; Jebbink, Merel...
JTO Clinical and Research Reports. 5 (2024) 4 - p. 100656 , 2024

Link: https://doi.org/10.1016/..

3

Exploring the impact of patient‐specific clinical features ..:

van Veelen, Ard ; Veerman, G. D. Marijn ; Verschueren, Marjon V....
International Journal of Cancer. 154 (2023) 2 - p. 332-342 , 2023

Link: https://doi.org/10.1002/..

4

Incidence of Bone Metastases and Skeletal-Related Events in..:

Brouns, Anita J.W. M. ; van Veelen, Ard ; Veerman, G. D. Marijn...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100513 , 2023

Link: https://doi.org/10.1016/..

5

Design and statistics of pharmacokinetic drug-drug, herb-dr..:

Lanser, Daan A.C. ; Van der Kleij, Maud B.A. ; Veerman, G.D. Marijn...
Biomedicine & Pharmacotherapy. 163 (2023) - p. 114823 , 2023

Link: https://doi.org/10.1016/..

6

Quantitation of osimertinib, alectinib and lorlatinib in hu..:

de Leeuw, Simon P. ; de Bruijn, Peter ; Koolen, Stijn L.W....
Journal of Pharmaceutical and Biomedical Analysis. 225 (2023) - p. 115233 , 2023

Link: https://doi.org/10.1016/..

7

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Ca..:

Pruis, Melinda A. ; Veerman, G.D. Marijn ; Hassing, H. Carlijne...
JACC: CardioOncology. 5 (2023) 1 - p. 102-113 , 2023

Link: https://doi.org/10.1016/..

8

Analysis of Serious Weight Gain in Patients Using Alectinib..:

de Leeuw, Simon P. ; Pruis, Melinda A. ; Sikkema, Barend J....
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1017-1030 , 2023

Link: https://doi.org/10.1016/..

9

Influence of germline variations in drug transporters ABCB1..:

Veerman, G.D. Marijn ; Boosman, Rene J. ; Jebbink, Merel...
eClinicalMedicine. 59 (2023) - p. 101955 , 2023

Link: https://doi.org/10.1016/..

10

Influence of esomeprazole on the bioavailability of afatini..:

Veerman, G.D. Marijn ; Hurkmans, Daan P. ; Paats, Marthe S....
Biomedicine & Pharmacotherapy. 155 (2022) - p. 113695 , 2022

Link: https://doi.org/10.1016/..

11

The influence of green tea extract on nintedanib's bioavail..:

Veerman, G.D.Marijn ; van der Werff, Sanne C. ; Koolen, Stijn L.W....
Biomedicine & Pharmacotherapy. 151 (2022) - p. 113101 , 2022

Link: https://doi.org/10.1016/..

12

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C. ; Veerman, G. D. Marijn ; Steendam, Christi M. J....
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211032 , 2022

Link: https://doi.org/10.1177/..

13

Clinical implications of germline variations for treatment ..:

Heersche, Niels ; Veerman, G.D. Marijn ; de With, Mirjam...
Drug Resistance Updates. 62 (2022) - p. 100832 , 2022

Link: https://doi.org/10.1016/..

14

To quantify the small-molecule kinase inhibitors ceritinib,..:

Veerman, G.D. Marijn ; de Bruijn, Peter ; Dingemans, Anne-Marie C...
Journal of Pharmaceutical and Biomedical Analysis. 193 (2021) - p. 113733 , 2021

Link: https://doi.org/10.1016/..

15

Randomized phase III study of docetaxel versus docetaxel pl..:

Steendam, Christi M.J. ; Peric, Robert ; van Walree, Nico C....
Lung Cancer. 160 (2021) - p. 44-49 , 2021

Link: https://doi.org/10.1016/..